Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.
暂无分享,去创建一个
[1] L. Voltolini,et al. Prognostic Nomogram to Predict Survival After Surgery for Synchronous Multiple Lung Cancers in Multiple Lobes , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] S. Fu,et al. Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials , 2015, Current medical research and opinion.
[3] L. Wilson,et al. Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] Shadil Ibrahim Wani,et al. Trigger factor assisted folding of the recombinant epoxide hydrolases identified from C. pelagibacter and S. nassauensis. , 2014, Protein expression and purification.
[5] J. Gui,et al. Role of a Genetic Variant on the 15q25.1 Lung Cancer Susceptibility Locus in Smoking-Associated Nasopharyngeal Carcinoma , 2014, PloS one.
[6] P. Chanvorachote,et al. Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells , 2014, PloS one.
[7] B. Melosky. Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer , 2014, Front. Oncol..
[8] Vincenzo Lagani,et al. Hidden Treasures in “Ancient” Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue , 2014, Front. Oncol..
[9] Guiping Wang,et al. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects , 2014, Journal of experimental & clinical cancer research : CR.
[10] L. Xian,et al. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer. , 2014, Genetics and molecular research : GMR.
[11] S. Oh,et al. The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer , 2014, Radiation oncology journal.
[12] Jie Fu,et al. Simvastatin inhibits the proliferation of A549 lung cancer cells through oxidative stress and up-regulation of SOD2. , 2014, Die Pharmazie.
[13] M. White,et al. The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study , 2014, British Journal of Cancer.
[14] Z. Zhang,et al. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. , 2014, Neoplasma.
[15] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[16] M. Gonsebatt,et al. Genetic Susceptibility to Lung Cancer Based on Candidate Genes in a Sample from the Mexican Mestizo Population: A Case–Control Study , 2014, Lung.
[17] M. Fathy,et al. Association Between Environmental Tobacco Smoke Exposure and Lung Cancer Susceptibility: Modification by Antioxidant Enzyme Genetic Polymorphisms , 2013, Molecular Diagnosis & Therapy.
[18] Y. Kakeji,et al. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: The Fukuoka Colorectal Cancer Study , 2013, Molecular carcinogenesis.
[19] L. Hou,et al. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene‐exposed workers , 2013, Environmental and molecular mutagenesis.
[20] Siwen Wang,et al. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer , 2013, Tumor Biology.
[21] Ding Yuan,et al. Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and Colorectal Cancer Risk , 2012, PloS one.
[22] Tariq Ahmad Masoodi,et al. Functional genomics based prioritization of potential nsSNPs in EPHX1, GSTT1, GSTM1 and GSTP1 genes for breast cancer susceptibility studies. , 2012, Genomics.
[23] C. Cacına,et al. Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society. , 2012, Genetic testing and molecular biomarkers.
[24] Leah E. Mechanic,et al. EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[25] Zhe Zhang,et al. Low microsomal epoxide hydrolase expression is associated with bladder carcinogenesis and recurrence. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[26] D. Dobrota,et al. Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population. , 2012, Neoplasma.
[27] B. Mittal,et al. Association of Functionally Important Polymorphism of Microsomal Epoxide Hydrolase Gene (EPHX1) With Lung Cancer Susceptibility , 2011, Cancer investigation.
[28] B. Ring,et al. Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis , 2011, PloS one.
[29] T. Isbir,et al. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. , 2010, Tumori.
[30] M. Arand,et al. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling , 2009, Archives of Toxicology.
[31] John D Potter,et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.
[32] D. Srivastava,et al. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India , 2008, Archives of Toxicology.
[33] R. D. Mittal,et al. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. , 2007, DNA and cell biology.
[34] William S. Beckett,et al. Asbestos-related lung disease. , 2007, American family physician.
[35] F. Oesch,et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.